| RS142007602 |
FANCM
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Hereditary cancer-predisposing syndrome |
| RS1420078244 |
CACNA1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 42 |
| RS142007879 |
TECTA
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS142008002 |
PROKR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypogonadotropic hypogonadism 3 with or without anosmia, Hypogonadotropic hypogonadism 3 with or without anosmia |
| RS142008044 |
NPHS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS142008398 |
SLX4
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group P |
| RS142009291 |
DTNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Left ventricular noncompaction 1, Left ventricular noncompaction 1 |
| RS142010751 |
ANK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spherocytosis type 1, Spherocytosis |
| RS1420107550 |
STARD9
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1420109925 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS142011043 |
KIFBP
|
Health Risk |
Conflicting classifications of pathogenicity |
Goldberg-Shprintzen syndrome, Goldberg-Shprintzen syndrome |
| RS142012270 |
FREM2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Isolated cryptophthalmia |
| RS142012387 |
PRF1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS142012621 |
IGF2
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Silver-Russell syndrome 3 |
| RS1420128252 |
ABCA4
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe early-childhood-onset retinal dystrophy, Severe early-childhood-onset retinal dystrophy |
| RS142013283 |
ATP6AP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Syndromic X-linked intellectual disability Hedera type, X-linked parkinsonism-spasticity syndrome |
| RS1420137773 |
SUMF1
|
Health Risk |
Pathogenic |
Multiple sulfatase deficiency, Multiple sulfatase deficiency |
| RS1420141860 |
LTBP2
|
Health Risk |
Pathogenic |
— |
| RS142014480 |
SLC5A5
|
Health Risk |
Conflicting classifications of pathogenicity |
Thyroid dyshormonogenesis 1, Inborn genetic diseases |
| RS1420151470 |
ERCC2
|
Health Risk |
Pathogenic |
— |
| RS142015707 |
ZFYVE26
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Inborn genetic diseases |
| RS1420159591 |
FLNC
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 26, Cardiomyopathy |
| RS142016609 |
RTTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS142016718 |
POMGNT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2O, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS142016804 |
LMNB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adult-onset autosomal dominant demyelinating leukodystrophy, Adult-onset autosomal dominant demyelinating leukodystrophy |
| RS142017360 |
APOB
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1420175816 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS142018195 |
COQ8B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS142018583 |
PEX1
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 1A (Zellweger), Zellweger spectrum disorders |
| RS142019309 |
RHBDF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Palmoplantar keratoderma-esophageal carcinoma syndrome, Inborn genetic diseases |
| RS142019870 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, APC-Associated Polyposis Disorders |
| RS142020270 |
SETX
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 4, Spinocerebellar ataxia |
| RS142021049 |
NPHP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis, NPHP3-related Meckel-like syndrome |
| RS142021066 |
COL6A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Collagen 6-related myopathy |
| RS1420211177 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1420217487 |
GALNT12
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS142022626 |
TTC21B
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis 12, Jeune thoracic dystrophy |
| RS142023538 |
FLNB
|
Health Risk |
Conflicting classifications of pathogenicity |
FLNB-Related Spectrum Disorders, FLNB-Related Spectrum Disorders |
| RS142023792 |
NSD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Sotos syndrome |
| RS1420243208 |
BARD1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS142024534 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Spastic paraplegia |
| RS142025193 |
FRMPD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, X-linked 104 |
| RS142025324 |
AP3B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hermansky-Pudlak syndrome 2, Autoinflammatory syndrome |
| RS142025489 |
FERMT3
|
Health Risk |
Conflicting classifications of pathogenicity |
Leukocyte adhesion deficiency 3, Leukocyte adhesion deficiency 3 |
| RS142027093 |
ANO5
|
Health Risk |
Pathogenic |
Gnathodiaphyseal dysplasia, Autosomal recessive limb-girdle muscular dystrophy type 2L |
| RS1420274633 |
MTOR
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS142027515 |
HPS3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome |
| RS142027562 |
PIEZO1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1420275854 |
TCTN1
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS1420280878 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS142028110 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1420285326 |
RPGR
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary ciliary dyskinesia, Retinal dystrophy |
| RS142029189 |
ZFYVE26
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Hereditary spastic paraplegia |
| RS1420292012 |
SHH
|
Health Risk |
Likely pathogenic |
Holoprosencephaly 3, Holoprosencephaly 3 |
| RS142029636 |
MANBA
|
Health Risk |
Likely pathogenic |
Beta-D-mannosidosis, Beta-D-mannosidosis |
| RS142030262 |
KCNJ1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bartter disease type 2, Bartter disease type 2 |
| RS1420307327 |
NPHS1
|
Health Risk |
Pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS142030898 |
TBK1
|
Health Risk |
Pathogenic; other |
Motor neuron disease, Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 |
| RS142031266 |
SPAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia 28, Primary ciliary dyskinesia |
| RS1420315178 |
TPP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive spinocerebellar ataxia 7, Neuronal ceroid lipofuscinosis 2 |
| RS1420316004 |
FANCG
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group G, Fanconi anemia complementation group G |
| RS1420321267 |
ACAT1
|
Health Risk |
Likely pathogenic |
Deficiency of acetyl-CoA acetyltransferase, Deficiency of acetyl-CoA acetyltransferase |
| RS1420322445 |
COL1A1
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS1420326474 |
RNF216
|
Health Risk |
Likely pathogenic |
— |
| RS142033335 |
VPS13D
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS142033533 |
PER2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS142034230 |
GSN
|
Health Risk |
Conflicting classifications of pathogenicity |
Finnish type amyloidosis, Inborn genetic diseases |
| RS1420347614 |
INF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Focal segmental glomerulosclerosis 5, Charcot-Marie-Tooth disease dominant intermediate E |
| RS1420354168 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS142036266 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 3 |
| RS142036299 |
CASQ2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Catecholaminergic polymorphic ventricular tachycardia 2 |
| RS142036463 |
PC
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyruvate carboxylase deficiency, Inborn genetic diseases |
| RS1420368113 |
PLA2G7
|
Health Risk |
Likely pathogenic |
Platelet-activating factor acetylhydrolase deficiency, Platelet-activating factor acetylhydrolase deficiency |
| RS142036980 |
LIPC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperlipidemia due to hepatic triglyceride lipase deficiency, Type 2 diabetes mellitus |
| RS142037029 |
AIP
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS142037381 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Migraine, familial hemiplegic |
| RS142037771 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Charlevoix-Saguenay spastic ataxia, Hereditary spastic paraplegia |
| RS142037828 |
ABCG5
|
Health Risk |
Conflicting classifications of pathogenicity |
Sitosterolemia, ABCG5-related disorder |
| RS142038079 |
ITK
|
Health Risk |
Conflicting classifications of pathogenicity |
Lymphoproliferative syndrome 1, Inborn genetic diseases |
| RS1420382294 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS142038240 |
RECQL
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, RECON progeroid syndrome |
| RS1420388292 |
CACNA1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Hypokalemic periodic paralysis |
| RS1420394583 |
FLNC
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Hypertrophic cardiomyopathy 26 |
| RS1420397443 |
GPT2
|
Health Risk |
Pathogenic |
Glutamate pyruvate transaminase 2 deficiency, Glutamate pyruvate transaminase 2 deficiency |
| RS1420399110 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS142040264 |
SLC34A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive hypophosphatemic bone disease, Autosomal recessive hypophosphatemic bone disease |
| RS142040996 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS1420414097 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS142041428 |
LAMC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1420414848 |
FAH
|
Health Risk |
Pathogenic/Likely pathogenic |
Tyrosinemia type I, Tyrosinemia type I |
| RS142041722 |
RELN
|
Health Risk |
Conflicting classifications of pathogenicity |
Norman-Roberts syndrome, Familial temporal lobe epilepsy 7 |
| RS1420420542 |
IFT80
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS1420427521 |
COL1A1
|
Health Risk |
Pathogenic |
— |
| RS1420431000 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS142043309 |
TRPM6
|
Health Risk |
Conflicting classifications of pathogenicity |
TRPM6-related disorder, Inborn genetic diseases |
| RS1420441572 |
VHL
|
Health Risk |
Conflicting classifications of pathogenicity |
Von Hippel-Lindau syndrome, Chuvash polycythemia |
| RS1420447960 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS142045411 |
COL3A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, type 4 |
| RS142046308 |
POU1F1
|
Health Risk |
Pathogenic |
Pituitary hormone deficiency, combined |
| RS142046356 |
GALNT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital disorder of glycosylation, type iit |